Table 3.
The baseline and perioperative data of SILS-C versus SILS-S.
| SILS-Ca (n = 53) | SILS-Sb (n = 50) | P-value | |
|---|---|---|---|
| Gender (%) | 0.870 | ||
| Female | 28 (52.83%) | 29 (58.00%) | |
| Male | 25 (47.17%) | 21 (42.00%) | |
| Age (SD), years | 8.11 (2.26) | 7.94 (2.08) | 0.921 |
| Height (SD), cm | 129 (14.01) | 126 (14.80) | 0.501 |
| Weight (SD), kg | 28.3 (9.46) | 25.2 (8.42) | 0.229 |
| BMI (SD), kg/m2 | 16.5 (2.66) | 15.6 (2.31) | 0.151 |
| Splenic long-axis (SD), cm | 20.2 (2.91) | 21.3 (2.72) | 0.158 |
| Primary disease (%) | 0.842 | ||
| α-thalassaemia | 44 (83.02%) | 38 (76.00%) | |
| β-thalassaemia | 8 (15.09%) | 9 (18.00%) | |
| Hereditary spherocytosis | 1 (1.89%) | 3 (6.00%) | |
| Operating time (SD), min | 172 (44.21) | 205 (47.90) | 0.003* |
| Blood loss (Min, Max), g | 15 (5, 365) | 20 (5, 290) | 0.121 |
| Pain score at Day 1 (SD)c | 3.08 (0.90) | 2.70 (0.89) | 0.109 |
| Pain score at Day 3 (SD)c | 1.11 (0.91) | 0.800 (0.83) | 0.198 |
| Anal exhaust time (SD), h | 24.70 (6.41) | 23.10 (8.91) | 0.601 |
| Postoperative hospital stay (SD), day | 4.83 (1.07) | 4.60 (0.99) | 0.529 |
| Complications (%) | 0.713 | ||
| No | 50 (94.34%) | 45 (90.00%) | |
| Yes | 3 (5.67%) | 5 (10.00%) |
a
The SILS with curved surgical instrumentation.
b
The SILS with straight surgical instrumentation.
c
FLACC: The primary outcome measure will be the pain rating using the Faces, Legs, Activity, Cry and Consolability Scale during the procedure.
*
P < 0.05.